Literature DB >> 4395481

Beta-adrenergic blocking therapy in hypertension: selection of patients.

E D Frohlich, R C Tarazi, H P Dustan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4395481

Source DB:  PubMed          Journal:  Int Z Klin Pharmakol Ther Toxikol


× No keyword cloud information.
  5 in total

1.  A controlled study on the antihypertensive effect of a new beta-adrenergic receptor blocking drug, metoprolol, in combination with chlorthalidone.

Authors:  A Jäättelä; K Pyörälä
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

2.  Differential antianginal responsiveness to acebutolol.

Authors:  P Biron; G Tremblay
Journal:  Eur J Clin Pharmacol       Date:  1975       Impact factor: 2.953

3.  Renin, aldosterone and arterial pressure responses to acute beta-adrenergic receptor blockage in hypertensive patients.

Authors:  K O Stumpe; R Kolloch; W Gramann; H Vetter; C Ressel; M Higuchi; F Krück
Journal:  Klin Wochenschr       Date:  1976-08-15

4.  Hypotensive effect of oxprenolol in mild to moderate hypertension: a multicentre controlled study.

Authors:  M Motolese; G Muiesan; A Colombi
Journal:  Eur J Clin Pharmacol       Date:  1975       Impact factor: 2.953

5.  Hypertensive labeling: does it have therapeutic implications.

Authors:  W H Birkenhäger
Journal:  Cardiovasc Drugs Ther       Date:  1993-04       Impact factor: 3.727
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.